Clinical Trial Update: Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated lenalidomide and rituximab in combination with chemotherapy for newly diagnosed diffuse large B-cell lymphoma or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma

Drugs mentioned

• Revlimid (lenalidomide)
• Rituxan (rituximab)

Snippet

Sponsor: Mayo Clinic | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-11-17